Phase III randomised double-blind controlled trial of oral risperidone, haloperidol or placebo with rescue subcutaneous midazolam for delirium management in palliative care
Version 2 2024-06-04, 10:05Version 2 2024-06-04, 10:05
Version 1 2022-11-25, 03:51Version 1 2022-11-25, 03:51
conference contribution
posted on 2024-06-04, 10:05authored byMeera Agar, Peter Lawlor, Steve Quinn, Gideon Caplan, Brian Draper, Debra Rowett, Linda Devilee, Belinda Fazekas, Christine Sanderson, Nicola McCaffery, Janet Hardy, Brian Le, Simon Eckermann, Mark Hill, David Currow
Phase III randomised double-blind controlled trial of oral risperidone, haloperidol or placebo with rescue subcutaneous midazolam for delirium management in palliative care